Achelios Therapeutics

About:

Achelios Therapeutics is a pharmaceutical development company advancing new product concepts through preclinical and early clinical POC.

Website: http://www.achelios.com

Description:

Achelios Therapeutics is a pharmaceutical development company that focuses on advancing new product concepts through the 505(b)(2) process to early clinical proof of principle followed by asset (project) sale. Achelios has adopted a semi-virtual model to control costs and advance projects by utilizing its experienced team and on-call external pharmaceutical experts and partners. This allows the company’s management to precisely tailor project needs with the right level of expertise and/or key opinion leaders with influence at the FDA, academic medical centers, and at the level of the payer (insurance company/government).

Total Funding Amount:

$3.52M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)exodosls.com

Founders:

Crist J. Frangakis

Number of Employees:

1-10

Last Funding Date:

2016-04-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai